Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,782.81
(
2.51%
)
US TECH 100
24,183.06
(
2.72%
)
Dow Jones
47,909.92
(
2.85%
)
Brent Oil
95.01
(
0.18%
)
Bitcoin
71,045.59
(
-0.12%
)
News Focus
News Focus
Post# of 447
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Jonathan Robinson

Send PM Follow Ignore
Followers 4
Posts 624
Boards Moderated 0
Alias Born 09/13/2004

Jonathan Robinson

Re: None

Thursday, 02/22/2007 7:53:19 AM

Thursday, February 22, 2007 7:53:19 AM

Post# of 447
After talking with FDA shortly, hoping to go back into Ph II with liquid dose while working on new tablet/gel formulations. Would then do a small bioequivalency study to move forward. Seems like a reasonable plan to me - thoughts?

Jon
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote